60 Degrees Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- 60 Degrees Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- SXTP
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001946563
Board of directors
-
Charles W. Allen · DirectorSince 2023
-
Cheryl Xu · DirectorSince 2023
-
Eric Francois · DirectorSince 2026
-
Geoffrey S. Dow · Director · President and CEOSince 2023
-
Paul Field · DirectorSince 2023
-
Stephen Toovey · DirectorSince 2023
Chief executives
Geoffrey S. Dow
· President and CEO
Since July 2023
Board connections
1 of this board's directors also sit on 1 other board.
- via Charles W. Allen
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $30,085
- 4 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2026 | Geoffrey S. Dow Director, Officer (President and CEO) | Open-market purchase | +7,350 | $1.38 | $10,143 |
| Dec 15, 2025 | Geoffrey S. Dow Director, Officer (President and CEO) | Open-market purchase | +9,670 | $0.80 | $7,736 |
| Dec 11, 2025 | Geoffrey S. Dow Director, Officer (President and CEO) | Open-market purchase | +3,613 | $0.92 | $3,324 |
| Dec 10, 2025 | Geoffrey S. Dow Director, Officer (President and CEO) | Open-market purchase | +9,350 | $0.95 | $8,883 |
| Sep 12, 2025 | Geoffrey S. Dow Director, Officer (President and CEO) | Grant or award | +7,201 | $1.39 | $10,009 |
| Jun 9, 2025 | Geoffrey S. Dow Director, Officer (President and CEO) | Grant or award | +4,376 | $2.99 | $13,084 |
| Jun 3, 2025 | Cheryl Xu Director | Open-market purchase | +3,000 | $2.87 | $8,610 |
| Jun 3, 2025 | Cheryl Xu Director | Open-market purchase | +2,000 | $2.90 | $5,800 |
| Jan 17, 2025 | Geoffrey S. Dow Director, Officer (President and CEO) | Grant or award | +14,394 | — | — |
| Jan 17, 2025 | MILLER TYRONE Officer (CFO) | Grant or award | +11,626 | — | — |
| Jan 17, 2025 | Landon Kristen Officer (Chief Operating Officer) | Grant or award | +4,540 | — | — |
| Dec 16, 2024 | Cheryl Xu Director | Open-market purchase | +2,000 | $1.45 | $2,900 |
| Dec 13, 2024 | Cheryl Xu Director | Open-market purchase | +1,500 | $1.60 | $2,400 |
| Dec 13, 2024 | Cheryl Xu Director | Open-market purchase | +1,500 | $1.58 | $2,370 |
| Dec 13, 2024 | Cheryl Xu Director | Open-market purchase | +1,500 | $1.55 | $2,325 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.